vs
Side-by-side financial comparison of DIODES INC (DIOD) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $391.6M, roughly 1.6× DIODES INC). Royalty Pharma plc runs the higher net margin — 34.4% vs 2.6%, a 31.8% gap on every dollar of revenue. On growth, DIODES INC posted the faster year-over-year revenue change (15.4% vs 4.8%). Over the past eight quarters, DIODES INC's revenue compounded faster (13.9% CAGR vs 4.6%).
Diodes Incorporated is a global semiconductor manufacturer that designs, produces and supplies discrete, analog and mixed-signal semiconductor products. Its solutions serve key end markets including automotive, industrial, consumer electronics, personal computing and communications infrastructure, with a worldwide customer base.
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
DIOD vs RPRX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $391.6M | $622.0M |
| Net Profit | $10.2M | $214.2M |
| Gross Margin | 31.1% | — |
| Operating Margin | 3.4% | 62.4% |
| Net Margin | 2.6% | 34.4% |
| Revenue YoY | 15.4% | 4.8% |
| Net Profit YoY | 23.8% | 2.9% |
| EPS (diluted) | $0.23 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $391.6M | $622.0M | ||
| Q3 25 | $392.2M | $609.3M | ||
| Q2 25 | $366.2M | $578.7M | ||
| Q1 25 | $332.1M | $568.2M | ||
| Q4 24 | $339.3M | $593.6M | ||
| Q3 24 | $350.1M | $564.7M | ||
| Q2 24 | $319.8M | $537.3M | ||
| Q1 24 | $302.0M | $568.0M |
| Q4 25 | $10.2M | $214.2M | ||
| Q3 25 | $14.3M | $288.2M | ||
| Q2 25 | $46.1M | $30.2M | ||
| Q1 25 | $-4.4M | $238.3M | ||
| Q4 24 | $8.2M | $208.2M | ||
| Q3 24 | $13.7M | $544.0M | ||
| Q2 24 | $8.0M | $102.0M | ||
| Q1 24 | $14.0M | $4.8M |
| Q4 25 | 31.1% | — | ||
| Q3 25 | 30.7% | — | ||
| Q2 25 | 31.5% | — | ||
| Q1 25 | 31.5% | — | ||
| Q4 24 | 32.7% | — | ||
| Q3 24 | 33.7% | — | ||
| Q2 24 | 33.6% | — | ||
| Q1 24 | 33.0% | — |
| Q4 25 | 3.4% | 62.4% | ||
| Q3 25 | 3.0% | 70.1% | ||
| Q2 25 | 2.6% | 36.3% | ||
| Q1 25 | 0.4% | 94.0% | ||
| Q4 24 | 3.5% | 60.9% | ||
| Q3 24 | 6.2% | — | ||
| Q2 24 | 1.2% | 50.2% | ||
| Q1 24 | 4.3% | -13.0% |
| Q4 25 | 2.6% | 34.4% | ||
| Q3 25 | 3.6% | 47.3% | ||
| Q2 25 | 12.6% | 5.2% | ||
| Q1 25 | -1.3% | 41.9% | ||
| Q4 24 | 2.4% | 35.1% | ||
| Q3 24 | 3.9% | 96.3% | ||
| Q2 24 | 2.5% | 19.0% | ||
| Q1 24 | 4.6% | 0.8% |
| Q4 25 | $0.23 | $0.49 | ||
| Q3 25 | $0.31 | $0.67 | ||
| Q2 25 | $0.99 | $0.07 | ||
| Q1 25 | $-0.10 | $0.55 | ||
| Q4 24 | $0.18 | $0.46 | ||
| Q3 24 | $0.30 | $1.21 | ||
| Q2 24 | $0.17 | $0.23 | ||
| Q1 24 | $0.30 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $377.0M | $618.7M |
| Total DebtLower is stronger | $25.7M | $9.0B |
| Stockholders' EquityBook value | $1.9B | $9.7B |
| Total Assets | $2.4B | $19.6B |
| Debt / EquityLower = less leverage | 0.01× | 0.92× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $377.0M | $618.7M | ||
| Q3 25 | $386.4M | $938.9M | ||
| Q2 25 | $327.3M | $631.9M | ||
| Q1 25 | $343.9M | $1.1B | ||
| Q4 24 | $316.1M | $929.0M | ||
| Q3 24 | $319.3M | $950.1M | ||
| Q2 24 | $273.9M | $1.8B | ||
| Q1 24 | $276.0M | $843.0M |
| Q4 25 | $25.7M | $9.0B | ||
| Q3 25 | $24.9M | $8.9B | ||
| Q2 25 | $26.4M | $8.0B | ||
| Q1 25 | $20.5M | $7.6B | ||
| Q4 24 | $20.7M | $7.6B | ||
| Q3 24 | $22.2M | $7.6B | ||
| Q2 24 | $20.3M | $7.6B | ||
| Q1 24 | $20.9M | $6.1B |
| Q4 25 | $1.9B | $9.7B | ||
| Q3 25 | $1.9B | $9.6B | ||
| Q2 25 | $1.9B | $9.5B | ||
| Q1 25 | $1.8B | $9.8B | ||
| Q4 24 | $1.8B | $10.3B | ||
| Q3 24 | $1.8B | $10.3B | ||
| Q2 24 | $1.8B | $9.8B | ||
| Q1 24 | $1.7B | $9.9B |
| Q4 25 | $2.4B | $19.6B | ||
| Q3 25 | $2.5B | $19.3B | ||
| Q2 25 | $2.5B | $18.3B | ||
| Q1 25 | $2.4B | $17.6B | ||
| Q4 24 | $2.4B | $18.2B | ||
| Q3 24 | $2.4B | $18.0B | ||
| Q2 24 | $2.4B | $17.7B | ||
| Q1 24 | $2.4B | $16.1B |
| Q4 25 | 0.01× | 0.92× | ||
| Q3 25 | 0.01× | 0.93× | ||
| Q2 25 | 0.01× | 0.84× | ||
| Q1 25 | 0.01× | 0.78× | ||
| Q4 24 | 0.01× | 0.74× | ||
| Q3 24 | 0.01× | 0.74× | ||
| Q2 24 | 0.01× | 0.78× | ||
| Q1 24 | 0.01× | 0.62× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $38.1M | $827.1M |
| Free Cash FlowOCF − Capex | $12.4M | — |
| FCF MarginFCF / Revenue | 3.2% | — |
| Capex IntensityCapex / Revenue | 6.6% | — |
| Cash ConversionOCF / Net Profit | 3.74× | 3.86× |
| TTM Free Cash FlowTrailing 4 quarters | $137.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $38.1M | $827.1M | ||
| Q3 25 | $79.1M | $702.6M | ||
| Q2 25 | $41.5M | $364.0M | ||
| Q1 25 | $56.7M | $596.1M | ||
| Q4 24 | $81.8M | $742.5M | ||
| Q3 24 | $54.4M | $703.6M | ||
| Q2 24 | $14.4M | $658.2M | ||
| Q1 24 | $-31.1M | $664.6M |
| Q4 25 | $12.4M | — | ||
| Q3 25 | $62.8M | — | ||
| Q2 25 | $21.1M | — | ||
| Q1 25 | $40.8M | — | ||
| Q4 24 | $62.1M | — | ||
| Q3 24 | $39.4M | — | ||
| Q2 24 | $-3.5M | — | ||
| Q1 24 | $-51.5M | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 12.3% | — | ||
| Q4 24 | 18.3% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | -1.1% | — | ||
| Q1 24 | -17.1% | — |
| Q4 25 | 6.6% | — | ||
| Q3 25 | 4.2% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 5.8% | — | ||
| Q3 24 | 4.3% | — | ||
| Q2 24 | 5.6% | — | ||
| Q1 24 | 6.7% | — |
| Q4 25 | 3.74× | 3.86× | ||
| Q3 25 | 5.54× | 2.44× | ||
| Q2 25 | 0.90× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 9.93× | 3.57× | ||
| Q3 24 | 3.95× | 1.29× | ||
| Q2 24 | 1.80× | 6.45× | ||
| Q1 24 | -2.22× | 139.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DIOD
| Distributor | $253.1M | 65% |
| Direct Sales | $138.5M | 35% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
